MARY JAMES: Open Payments
NPI 1215932272 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 37 payments from 18 companies in 2025. Trend: 2023 $910 · 2024 $957 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $122 |
| Novo Nordisk Inc | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| GENZYME CORPORATION | 1 | $49 |
| Amgen Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $29 |
Products named: REXULTI, NURTEC ODT, Rybelsus, TRELEGY ELLIPTA, DUPIXENT, EVENITY, BREZTRI, M-M-R II.
Industry payments across CA — which companies pay providers there.
